Back to News

Outlook Therapeutics CFO Kenyon acquires 101,010 shares

Article content is unavailable (HTTP 403), so no news facts, figures, or market implications could be extracted.

Analysis

Article content is unavailable (HTTP 403), so no news facts, figures, or market implications could be extracted.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News